George Washington University (GW) researcher Aileen Chang, MD, MSPH, is a finalist for CureAccelerator Live! for the Developing World. The event is a philanthropic pitch competition that gives attendees the chance to select and award $50,000 of funding for the next breakthrough clinical repurposing treatment.
Aileen Chang, MD, MSPH, is a Finalist for CureAccelerator Live!
Latest News
We are thrilled to announce that The Chang Lab is currently enrolling participants for our groundbreaking clinical trials being conducted in Barranquilla, Colombia! This marks a significant step forward in our translational research efforts.
In 2020, Cures Within Reach funded Dr. Aileen Chang at George Washington University to support a Phase I trial evaluating the safety and efficacy of an approved flu drug, zanamivir, for patients with severe dengue infections in Colombia.
Dengue viruses (DenV) are among the leading causes of pediatric morbidity and mortality globally, with 96 million symptomatic cases annually worldwide and no targeted treatments.